Should you invest $1,000 in Vanguard Ftse Canadian High Dividend Yield Index Etf right now?

Before you buy stock in Vanguard Ftse Canadian High Dividend Yield Index Etf, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Vanguard Ftse Canadian High Dividend Yield Index Etf wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

See the Top Stocks * Returns as of 2/20/25

Buy Alert: 2 Marijuana Stocks That Could Double Your Investment In 2021

If you expect cannabis stocks to stage a turnaround in 2021, you can look to invest in these two marijuana heavyweights.

| More on:

For the last decade, big tech has dominated discussions within the investment community, and for good reason. Shares of Apple, Facebook, Amazon, Microsoft, and Alphabet have easily crushed the broader markets since the financial crisis of 2008-09.

Even amid the pandemic, these tech heavyweights are primarily responsible for the market recovery since March 2020. The big tech companies were expected to grow at an enviable rate and they have not disappointed investors.

However, when it comes to investing in growth stocks, cannabis companies are not far behind. The marijuana industry has been hit by valuation concerns, high tax rates, low profitability, and a slew of other structural issues in the last two years. But there is a good chance that the pot stocks have bottomed out and may move higher in 2021.

Here we look at two such cannabis giants that can easily double your money in 2021.

Green Thumb Industries

The first cannabis company on the list is Green Thumb Industries (CNSX:GTII), a multistate operator in the U.S. Green Thumb has 49 operational dispensaries in 12 states south of the border. It has focused its expansion efforts in its home state of Illinois, which legalized recreational cannabis in January 2020.

Shares of Green Thumb Industries have returned 69% in 2020 and are well poised to move higher in 2021 and beyond. The company’s huge presence in Illinois and its growing market share in the tourist-heavy state of Nevada will be the primary drivers of top-line growth.

These two states might also generate US$1 billion in annual sales by 2024 which means Green Thumb’s growth story remains intact. Green Thumb generates over 65% of sales from higher-margin derivatives products, allowing the firm to consistently post a positive EBITDA and net income at a time when peers are burning cash at an alarming rate.

Charlotte’s Web Holdings

Charlotte’s Web Holdings (TSX:CWEB) investors have lost over 50% year-to-date. The stock has in fact lost 86% in market value since August 2019. In the June quarter, Charlotte’s sales were down 13.6% year-over-year at US$21.6 million. Its DTC or online sales accounted for 72% of sales and rose by a healthy 33.6% year-over-year. However, the company’s lower in-store sales and foot traffic due to the pandemic resulted in a revenue decline for the June quarter.

Another matter of concern for investors was Charlotte’s widening losses that stood at US$14.4 million in Q2 compared to a net income of US$2.2 million in the prior-year period. The company’s administrative expenses were in fact as much as its revenue which has contributed to the stock’s less than impressive performance in 2020.

However, Charlotte’s expects revenue growth to gain pace in the second half of 2020 as customers return to stores, resulting in higher traffic. Further, the shift in shopping trends will continue to increase its DTC sales in the next several quarters.

Charlotte’s reported a healthy gross margin of 64.8% in Q2m which means it has enough room to focus on cost optimization and improve the bottom line. Analysts tracking the stock expect sales to increase by just 3.1% to US$97.5 million in 2020.

However, Wall Street expects sales to touch $146 million in 2021, which will also increase its adjusted net income to $0.04 per share, compared to a net loss of $0.3 per share in 2020.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. David Gardner owns shares of Alphabet (A shares), Alphabet (C shares), Amazon, Apple, and Facebook. Tom Gardner owns shares of Alphabet (A shares), Alphabet (C shares), and Facebook. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Amazon, Apple, Charlottes Web Holdings, Facebook, and Microsoft and recommends the following options: long January 2022 $1920 calls on Amazon, long January 2021 $85 calls on Microsoft, short January 2021 $115 calls on Microsoft, and short January 2022 $1940 calls on Amazon. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »